Evolent Health, Inc. (EVH) Q4 2025 Earnings Call Transcript
2026-02-25 12:27:48 ET
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call February 24, 2026 5:00 PM EST
Company Participants
Seth Blackley - Co-Founder, CEO & Director
Mario Ramos - Chief Financial Officer
Conference Call Participants
Lucas Romanski - TD Cowen, Research Division
John Stansel - JPMorgan Chase & Co, Research Division
Daniel Grosslight - Citigroup Inc., Research Division
Jailendra Singh - Truist Securities, Inc., Research Division
Jared Haase - William Blair & Company L.L.C., Research Division
Jessica Tassan - Piper Sandler & Co., Research Division
Jeffrey Garro - Stephens Inc., Research Division
Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division
Richard Close - Canaccord Genuity Corp., Research Division
David Larsen - BTIG, LLC, Research Division
Matthew Shea - Needham & Company, LLC, Research Division
Sean Dodge - BMO Capital Markets Equity Research
Kevin Caliendo - UBS Investment Bank, Research Division
Ryan Halsted - RBC Capital Markets, Research Division
...
Read the full article on Seeking Alpha
For further details see:
Evolent Health, Inc. (EVH) Q4 2025 Earnings Call TranscriptNASDAQ: EVH
EVH Trading
-4.89% G/L:
$3.015 Last:
1,619,755 Volume:
$3.06 Open:



